Society of Interventional Radiology elevates 23 new Fellows during Annual Scientific Meeting in Atlanta

The Society of Interventional Radiology (SIR) elevated 23 new Fellows during the society's Annual Scientific Meeting, Feb. 28-March 5 in Atlanta. This honor, achieved by fewer than 10 percent of SIR membership, goes to members who have demonstrated excellence in research and published works or teaching and leadership within the field of interventional radiology and the society.

"This is a prestigious honor conferred by the society to those members who are passionate in their commitment to improving medical practice by developing, testing and implementing breakthrough treatments," said SIR President James B. Spies, M.D., MPH, FSIR, who represents more than 5,000 doctors, scientists and allied health professionals dedicated to improving health care through image-guided, minimally invasive treatments. "Each of these interventional radiologists has made special contributions to the profession through their accomplishments in research, patient care and leadership," added Spies, who is an interventional radiologist and chair of the radiology department at MedStar Georgetown University Hospital, in Washington, D.C.

Of those selected to be SIR Fellows, 18 were named Active Fellows and five were named Corresponding Fellows (members who practice and/or reside outside of the United States). SIR Active Fellows include Kimi L. Kondo, DO, FSIR, University of Colorado, Aurora; Charles F. Tate III, M.D., FSIR, IR Associates of Fort Lauderdale, Fla.; Abbas Chamsuddin, M.D., FSIR, Newton Medical Center, Covington, Ga.; James T. Bui, M.D., FSIR, University of Illinois Hospital, Chicago; Thuong G. Van Ha, M.D., FSIR, University of Chicago Hospital; Daniel E. Wertman, M.D., FSIR, Indiana University Medical Center, Indianapolis; Muneeb Ahmed, M.D., FSIR, Beth Israel Deaconess Medical Center, and Dmitry Rabkin, M.D., FSIR, Brigham and Women's Hospital Boston, both Boston, Mass., and Sidney Lowell Kahn, M.D., FSIR, Baystate Medical Center, Springfield, Mass.; Nadine Abi-Jaoudeh, M.D., FSIR, National Institutes of Health, Bethesda, Md.; Michael A. Savin, M.D., FSIR, William Beaumont Hospital, Royal Oak, Mich.; Neil M. Khilnani, M.D., FSIR, Weill Cornell Vascular, New York, N.Y.; Charles Y. Kim, M.D., FSIR, Duke University Medical Center, Durham, N.C.; Mark L. Montgomery, M.D., FSIR, Scott and White Clinic, Temple, Texas; Aradhana M. Venkatesan, M.D., FSIR, MD Anderson Cancer Center Houston, Texas; John D. Statler, M.D., FSIR, Virginia Interventional and Vascular Associates, Fredericksburg, Va., and Eric J. Hohenwalter, M.D., FSIR, Medical College of Wisconsin, Milwaukee, and Timothy L. Swan, M.D., FSIR, Marshfield Clinic, Marshfield, both Wisconsin.